BIOMAT Database Logo BIOMAT Database Logo

Structure-activity study of pentamidine analogues as antiprotozoal agents. 2009

Svetlana M Bakunova, and Stanislav A Bakunov, and Donald A Patrick, and E V K Suresh Kumar, and Kwasi A Ohemeng, and Arlene S Bridges, and Tanja Wenzler, and Todd Barszcz, and Susan Kilgore Jones, and Karl A Werbovetz, and Reto Brun, and Richard R Tidwell
Department of Pathology and Laboratory Medicine, School of Medicine, The University of North Carolina, Chapel Hill, North Carolina 27599, USA.

Diamidine 1 (pentamidine) and 65 analogues (2-66) have been tested for in vitro antiprotozoal activities against Trypanosoma brucei rhodesiense, Plasmodium falciparum, and Leishmania donovani, and for cytotoxicity against mammalian cells. Dications 32, 64, and 66 exhibited antitrypanosomal potencies equal or greater than melarsoprol (IC(50) = 4 nM). Nine congeners (2-4, 12, 27, 30, and 64-66) were more active against P. falciparum than artemisinin (IC(50) = 6 nM). Eight compounds (12, 32, 33, 44, 59, 62, 64, and 66) exhibited equal or better antileishmanial activities than 1 (IC(50) = 1.8 microM). Several congeners were more active than 1 in vivo, curing at least 2/4 infected animals in the acute mouse model of trypanosomiasis. The diimidazoline 66 was the most promising compound in the series, showing excellent in vitro activities and high selectivities against T. b. rhodesiense, P. falciparum, and L. donovani combined with high antitrypanosomal efficacy in vivo.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007893 Leishmania donovani A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes visceral leishmaniasis (LEISHMANIASIS, VISCERAL). The sandfly genera Phlebotomus and Lutzomyia are the vectors. Leishmania (Leishmania) donovani,Leishmania leishmania donovani,Leishmania donovanus,Leishmania leishmania donovanus,donovani, Leishmania leishmania,donovanus, Leishmania,donovanus, Leishmania leishmania,leishmania donovanus, Leishmania
D010419 Pentamidine Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects. Pentamidine Isethionate,Diamidine,Lomidine,NebuPent,Pentacarinat,Pentam,Pentamidin,Pentamidine Mesylate
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D002103 Cadaverine A foul-smelling diamine formed by bacterial DECARBOXYLATION of LYSINE. It is also an intermediate secondary metabolite in lysine-derived alkaloid biosynthetic pathways (e.g., QUINOLIZIDINES and LYCOPODIUM). 1,5-Pentanediamine,BioDex 1,Pentamethylenediamine,1,5 Pentanediamine
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Svetlana M Bakunova, and Stanislav A Bakunov, and Donald A Patrick, and E V K Suresh Kumar, and Kwasi A Ohemeng, and Arlene S Bridges, and Tanja Wenzler, and Todd Barszcz, and Susan Kilgore Jones, and Karl A Werbovetz, and Reto Brun, and Richard R Tidwell
Structure-Activity Relationships of Cinnamate Ester Analogues as Potent Antiprotozoal Agents.
January 2020, ChemMedChem,
Svetlana M Bakunova, and Stanislav A Bakunov, and Donald A Patrick, and E V K Suresh Kumar, and Kwasi A Ohemeng, and Arlene S Bridges, and Tanja Wenzler, and Todd Barszcz, and Susan Kilgore Jones, and Karl A Werbovetz, and Reto Brun, and Richard R Tidwell
Structure-in vitro activity relationships of pentamidine analogues and dication-substituted bis-benzimidazoles as new antifungal agents.
October 1998, Antimicrobial agents and chemotherapy,
Svetlana M Bakunova, and Stanislav A Bakunov, and Donald A Patrick, and E V K Suresh Kumar, and Kwasi A Ohemeng, and Arlene S Bridges, and Tanja Wenzler, and Todd Barszcz, and Susan Kilgore Jones, and Karl A Werbovetz, and Reto Brun, and Richard R Tidwell
Dicationic phenyl-2,2'-bichalcophenes and analogues as antiprotozoal agents.
January 2011, Bioorganic & medicinal chemistry,
Svetlana M Bakunova, and Stanislav A Bakunov, and Donald A Patrick, and E V K Suresh Kumar, and Kwasi A Ohemeng, and Arlene S Bridges, and Tanja Wenzler, and Todd Barszcz, and Susan Kilgore Jones, and Karl A Werbovetz, and Reto Brun, and Richard R Tidwell
Investigation of 5'-Norcarbocyclic Nucleoside Analogues as Antiprotozoal and Antibacterial Agents.
September 2019, Molecules (Basel, Switzerland),
Svetlana M Bakunova, and Stanislav A Bakunov, and Donald A Patrick, and E V K Suresh Kumar, and Kwasi A Ohemeng, and Arlene S Bridges, and Tanja Wenzler, and Todd Barszcz, and Susan Kilgore Jones, and Karl A Werbovetz, and Reto Brun, and Richard R Tidwell
Biological evaluation and structure-activity relationships of imidazole-based compounds as antiprotozoal agents.
August 2018, European journal of medicinal chemistry,
Svetlana M Bakunova, and Stanislav A Bakunov, and Donald A Patrick, and E V K Suresh Kumar, and Kwasi A Ohemeng, and Arlene S Bridges, and Tanja Wenzler, and Todd Barszcz, and Susan Kilgore Jones, and Karl A Werbovetz, and Reto Brun, and Richard R Tidwell
Design, synthesis and in vitro antiprotozoal activity of benzimidazole-pentamidine hybrids.
June 2008, Bioorganic & medicinal chemistry letters,
Svetlana M Bakunova, and Stanislav A Bakunov, and Donald A Patrick, and E V K Suresh Kumar, and Kwasi A Ohemeng, and Arlene S Bridges, and Tanja Wenzler, and Todd Barszcz, and Susan Kilgore Jones, and Karl A Werbovetz, and Reto Brun, and Richard R Tidwell
Synthesis and structure-activity relationships of lansine analogues as antileishmanial agents.
November 2012, ChemMedChem,
Svetlana M Bakunova, and Stanislav A Bakunov, and Donald A Patrick, and E V K Suresh Kumar, and Kwasi A Ohemeng, and Arlene S Bridges, and Tanja Wenzler, and Todd Barszcz, and Susan Kilgore Jones, and Karl A Werbovetz, and Reto Brun, and Richard R Tidwell
New prodrugs of the antiprotozoal drug pentamidine.
December 2011, ChemMedChem,
Svetlana M Bakunova, and Stanislav A Bakunov, and Donald A Patrick, and E V K Suresh Kumar, and Kwasi A Ohemeng, and Arlene S Bridges, and Tanja Wenzler, and Todd Barszcz, and Susan Kilgore Jones, and Karl A Werbovetz, and Reto Brun, and Richard R Tidwell
Structure activity relationship study of burkholdine analogues toward simple antifungal agents.
August 2015, Bioorganic & medicinal chemistry letters,
Svetlana M Bakunova, and Stanislav A Bakunov, and Donald A Patrick, and E V K Suresh Kumar, and Kwasi A Ohemeng, and Arlene S Bridges, and Tanja Wenzler, and Todd Barszcz, and Susan Kilgore Jones, and Karl A Werbovetz, and Reto Brun, and Richard R Tidwell
Development of pentamidine analogues as new agents for the treatment of Pneumocystis carinii pneumonia.
January 1990, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!